[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354118-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354118-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","microenvironment-activated-fe-mof-nanoplatform-enables-controlled-doxorubicin-release-and-ferroptosis-associated-oxidative-damage-in-mcf-7-breast-cancer-cells","Microenvironment-Activated Fe-MOF Nanoplatform Enables Controlled Doxorubicin Release and Ferroptosis-Associated Oxidative Damage in MCF-7 Breast Cancer Cells","","Doxorubicin is a cornerstone breast-cancer chemotherapeutic, yet limited by inefficient intracellular delivery and off-target toxicity. A microenvironment-responsive core–shell UTMD was built by coating an NH2-MIL-88B(Fe) Fe-MOF onto a UCNP@TiO2 scaffold, using Fe-MOF as a dual pH- and GSH-responsive gatekeeper. UTMD showed high encapsulation (86.5%), stable physiological behavior, accelerated DOX release in acidic/reducing conditions, enhanced internalization and nuclear accumulation, and ferroptosis-consistent oxidative damage in MCF-7 cells while improving cytocompatibility in HEK-293.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/microenvironment-activated-fe-mof-nanoplatform-enables-controlled-doxorubicin-release-and-ferroptosis-associated-oxidative-damage-in-mcf-7-breast-cancer-cells/354118/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/microenvironment-activated-fe-mof-nanoplatform-enables-controlled-doxorubicin-release-and-ferroptosis-associated-oxidative-damage-in-mcf-7-breast-cancer-cells/354118.png","ImageObject",300,407,{"name":42,"@type":43},"Bintang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main design goal of the UTMD nanoplatform?","Question",{"text":63,"@type":64},"UTMD is engineered as a microenvironment-activated system that couples controlled doxorubicin release with ferroptosis-associated oxidative stress in tumor cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does UTMD trigger doxorubicin release?",{"text":68,"@type":64},"The Fe-MOF shell functions as a dual pH- and GSH-responsive gatekeeper, accelerating release under acidic and reducing conditions.",{"name":70,"@type":61,"acceptedAnswer":71},"What cellular effects support ferroptosis-associated oxidative damage?",{"text":72,"@type":64},"In MCF-7 cells, UTMD causes GSH depletion, increased reactive oxygen species, elevated lipid peroxidation, and mitochondrial membrane potential depolarization.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354118,1790384742,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085564381,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","International Journal of Nanomedicine  \n Open Access Full Text Article  \nORIGINAL RESEARCH  \nMicroenvironment-Activated Fe-MOF Nanoplatform Enables Controlled Doxorubicin Release and Ferroptosis-Associated Oxidative Damage in MCF-7 Breast Cancer Cells  \nMiao Yuan 1 , *, Yang Wu 1 , *, Jing Zheng 1 , *, Chaoran Wang 1 , Jiarong Wang 1 , Yifan Zheng 1 , Yunqi Wang 1 , Baiqi Wang 1 , 2  \n1Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin, 300070, People’s Republic of China; 2National Demonstration Center for Experimental Preventive Medicine Education (Tianjin Medical University), Tianjin, 300070, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Baiqi Wang, Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, No. 22, Qixiangtai Road, Heping Dist, Tianjin, 300070, People’s Republic of China, Tel +86-22-83336630, Fax +86-22-83336603, [Email wangbaiqi@tmue.edu.cn](Email wangbaiqi@tmue.edu.cn)  \n\n| Introduction: Doxorubicin (DOX) is a cornerstone chemotherapeutic for breast cancer; however, its clinical efficacy is limited by inefficient intracellular delivery and dose-limiting off-target toxicity. Microenvironment-responsive nanoplatforms offer a promising strategy to enhance tumor selectivity and therapeutic performance.\u003Cbr>Methods: A core–shell nanosystem (UTMD) was constructed by coating an NH2-MIL-88B(Fe) metal–organic framework (Fe-MOF) shell onto a UCNP@TiO2 scaffold. The Fe-MOF shell was designed as a dual pH-and glutathione (GSH)-responsive gatekeeper for controlled DOX release. The nanosystem was characterized for structural features, drug loading, and stimulus-responsive release behavior. Cellular uptake, intracellular trafficking, cytotoxicity, and redox-related biochemical changes were evaluated in MCF-7 breast cancer cells and HEK-293 normal cells.\u003Cbr>Results: UTMD achieved high encapsulation efficiency (86.5%) and maintained stability under physiological conditions, while enabling accelerated DOX release in acidic and reducing environments. The nanosystem enhanced cellular internalization and promoted nuclear accumulation of DOX in MCF-7 cells. In addition, UTMD induced significant intracellular redox imbalance, characterized by GSH depletion, increased reactive oxygen species levels, and elevated lipid peroxidation, accompanied by mitochondrial membrane potential depolarization. These changes are consistent with ferroptosis-associated oxidative damage. Compared with free DOX, UTMD exhibited improved cytocompatibility in HEK-293 cells.\u003Cbr>Discussion: The Fe-MOF shell functions as a microenvironment-responsive gatekeeper that coordinates controlled drug release with iron-mediated oxidative stress. This integrated design links chemotherapy with ferroptosis-associated mechanisms, improving therapeutic selectivity and mechanistic interpretability.\u003Cbr>Conclusion: UTMD represents a microenvironment-activated nanoplatform that enables controlled DOX delivery and ferroptosisassociated oxidative damage. This strategy enhances antitumor efficacy while reducing off-target toxicity, offering potential for improved breast cancer therapy.\u003Cbr>Keywords: Fe-based metal–organic framework, pH/GSH-responsive nanoplatform, doxorubicin delivery, ferroptosis, lipid peroxidation, breast cancer |\n| --- |\n| Introduction\u003Cbr>Breast cancer remains one of the most common malignancies worldwide and a leading cause of cancer-related mortality among women.1,2 Although breast cancer diagnosis and treatment have advanced considerably, long-term clinical control |\n\n[https://doi.org/10.2147/IJN.S604452](https://doi.org/10.2147/IJN.S604452)  \n[Received: 21 February 2026](Received: 21 February 2026)  \n[Accepted: 24 April 2026](Accepted: 24 April 2026)  \n[Published: 1 May 2026](Published: 1 May 2026)  \nInternational Journal of Nanomedicine 2026:21 604452 1  \n© 2026 Yuan et al. This work is published","cbCaitM69zkLqIgR","https://ap.wps.com/l/cbCaitM69zkLqIgR","pdf",12303441,21,"English","# Introduction\n## Methods\n## Results\n## Discussion\n## Conclusion\n## Keywords","[{\"question\":\"What is the main design goal of the UTMD nanoplatform?\",\"answer\":\"UTMD is engineered as a microenvironment-activated system that couples controlled doxorubicin release with ferroptosis-associated oxidative stress in tumor cells.\"},{\"question\":\"How does UTMD trigger doxorubicin release?\",\"answer\":\"The Fe-MOF shell functions as a dual pH- and GSH-responsive gatekeeper, accelerating release under acidic and reducing conditions.\"},{\"question\":\"What cellular effects support ferroptosis-associated oxidative damage?\",\"answer\":\"In MCF-7 cells, UTMD causes GSH depletion, increased reactive oxygen species, elevated lipid peroxidation, and mitochondrial membrane potential depolarization.\"}]","Microenvironment-Activated Fe-MOF Nanoplatform Enables Controlled Doxorubicin Release and Ferroptosis-Associated Oxidative Damage in MCF-7 Breast Cancer Cells | PDF",1790109087,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee414b61babc26a4efd8b78cd6787129.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac23b5b30bcf2905085e500392e65311.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/36c7e603a783293053c65a4d4c7b0068.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55eef3efb669ff522d0d54afbf91d68d.webp",980,1268]